ArticleScientific reports2025

Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment.

Jens Bjelke Kristensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.